Markers of Inflammation Are Generally Elevated in Schizophrenia-Spectrum Disorders
Investigators searched publication databases for studies reporting biomarkers for inflammation in schizophrenia-spectrum disorders.
Diagnosis & Disease Information
Schizophrenia Early Intervention Had No Lasting Effects at 20 Years
In this study, the changes in Scale for Assessment for Positive Symptoms, Scale for Assessment of Negative Symptoms, and Global Assessment of Functioning scale outcomes over 20 years were evaluated.
Hospitalization Linked With Substance Use and Psychiatric Disorders in COVID-19
Investigators sought to evaluate the association of comorbid PD and SUD with the probability of hospitalization among patients with COVID-19 in the emergency department.
Children With Poor Motor Function and a Parent With Schizophrenia Are At Risk for Psychosis
In this analysis, the children who had 1 or both parents with schizophrenia or bipolar disorder were matched with children without familial high risk for psychosis.
Schizophrenia and Napping Frequency Have Bidirectional Genetic Relationship
Investigators sourced data for this study from the United Kingdom Biobank, 23andMe, and the Psychiatric Genomics Consortium dataset.
Rykindo Approved for Schizophrenia, Bipolar Disorder
The approval was based on data from adequate and well-controlled studies with risperidone long-acting injection (intramuscular).
Aripiprazole 2-Month Under Review for Schizophrenia, Bipolar I Disorder
The NDA is supported by data from a phase 1/2 trial that compared the investigational aripiprazole 2-month, long-acting injectable to aripiprazole 1-month depot.
Xanomeline-Trospium Improves Schizophrenia Symptoms in Phase 3 Trial
The phase 3 EMERGENT-2 trial included 252 patients with schizophrenia who were experiencing symptoms of psychosis.
Speech-Gesture Training Improves Quality of Life for Patients With Schizophrenia
To assess the impact of multimodal speech-gesture training on patients’ communication abilities, investigators conducted a randomized waiting list-controlled pilot trial at a university in Marburg, Germany.
Cognitive Enhancement Therapy May Improve Some Schizophrenia Symptoms
The researchers conducted secondary analysis of a multi-site CET trial using 86 individuals recently diagnosed with a schizophrenia spectrum disorder.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...